Powerful, integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients.
Powerful, integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients.
Focus: Real-world oncology data and AI-driven SaaS for life sciences
Headquarters: Cambridge/Boston, Massachusetts, USA
Founded: 2018
Employees: 871
Known funding: Raised >$230M; Series C led by Sixth Street (Mar 2022), post-money valuation reported $1.9B
Real-world data (RWD) aggregation and AI solutions for oncology and life sciences.
2018
Healthcare; Life Sciences; AI
Post-investment valuation reported at $1.9 billion
“Backed by strategic and institutional investors including SAI Group (SymphonyAI), Sixth Street, Declaration Partners, Maverick Ventures, and AllianceBernstein private credit/growth”